Live News EQUITY FLASH L impact Nov 17, 2026, 09:15 PM UTC Merck Updates BELLWAVE Clinical Development Program Merck announced an update on its BELLWAVE clinical development program evaluating nemtabrutinib. MRK SquawkNews Desk